161 related articles for article (PubMed ID: 87199)
1. Dihydro- and tetrahydroisoquinolines as inhibitors of cyclic nucleotide phosphodiesterases from dog heart. Structure-activity relationships.
Van Inwegen RG; Salaman P; St Georgiev V; Weinryb I
Biochem Pharmacol; 1979 Apr; 28(8):1307-12. PubMed ID: 87199
[No Abstract] [Full Text] [Related]
2. Methylxanthine inhibitors of phosphodiesterases.
Wells JN; Miller JR
Methods Enzymol; 1988; 159():489-96. PubMed ID: 2457788
[No Abstract] [Full Text] [Related]
3. Inhibition of human lung cyclic GMP and cyclic AMP phosphodiesterases by certain nucleosides, nucleotides, and pharmacological phosphodiesterase inhibitors.
Glass WF; Moore JB
Biochem Pharmacol; 1979 Apr; 28(7):1107-12. PubMed ID: 87197
[No Abstract] [Full Text] [Related]
4. Selective inhibition of cyclic AMP and cyclic GMP phosphodiesterases of cardiac nuclear fraction.
Ahluwalia GS; Rhoads AR
Biochem Pharmacol; 1982 Mar; 31(5):665-9. PubMed ID: 6177320
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the relationship between pharmacological inhibition of cyclic nucleotide phosphodiesterase and relaxation of canine tracheal smooth muscle.
Polson JB; Krzanowski JJ; Anderson WH; Fitzpatrick DF; Hwang DP; Szentivanyi A
Biochem Pharmacol; 1979 Apr; 28(8):1391-5. PubMed ID: 87201
[No Abstract] [Full Text] [Related]
6. [Pharmacologic value of cyclic nucleotide phosphodiesterase inhibitors].
Nemoz G; Prigent AF
Ann Pharm Fr; 1984; 42(2):99-112. PubMed ID: 6091520
[No Abstract] [Full Text] [Related]
7. Pharmacological inhibition of calmodulin-sensitive phosphodiesterases.
Ilien B; Ruckstuhl M; Landry Y
J Pharmacol; 1982; 13(2):307-16. PubMed ID: 6285085
[TBL] [Abstract][Full Text] [Related]
8. Cyclic nucleotide phosphodiesterase activities of the embryonic chick ovary.
Teng CT; Buchler B; Teng CS
Gen Comp Endocrinol; 1981 Aug; 44(4):409-17. PubMed ID: 6167486
[No Abstract] [Full Text] [Related]
9. Inhibition of lung cyclic AMP- and cyclic GMP-phosphodiesterases by flavonoids and other chromone-like compounds.
Ruckstuhl M; Landry Y
Biochem Pharmacol; 1981 Apr; 30(7):697-702. PubMed ID: 6264919
[No Abstract] [Full Text] [Related]
10. Selective inhibition of separated forms of cyclic nucleotide phosphodiesterase from rat heart by some pentasubstituted quercetin analogs.
Picq M; Prigent AF; Nemoz G; Pacheco H
Biochem Pharmacol; 1982 Sep; 31(17):2777-82. PubMed ID: 6291544
[TBL] [Abstract][Full Text] [Related]
11. 1-(4-Aminobenzyl)-and 1-(4-aminophenyl)isoquinoline derivatives: synthesis and evaluation as potential irreversible cyclic nucleotide phosphodiesterase inhibitors.
Walker KA; Boots MR; Stubbins JF; Rogers ME; Davis CW
J Med Chem; 1983 Feb; 26(2):174-81. PubMed ID: 6298424
[TBL] [Abstract][Full Text] [Related]
12. Cyclic nucleotide phosphodiesterases from frog atrial fibers: isolation and drug sensitivities.
Lugnier C; Gauthier C; Le Bec A; Soustre H
Am J Physiol; 1992 Mar; 262(3 Pt 2):H654-60. PubMed ID: 1373036
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of cyclic nucleotides and their analogs and various agents on cyclic GMP-specific and cyclic AMP-specific phosphodiesterases purified from guinea pig lung.
Davis CW; Kuo JF
Biochem Pharmacol; 1978 Jan; 27(1):89-95. PubMed ID: 202285
[No Abstract] [Full Text] [Related]
14. Phosphodiesterase inhibitors as tools in cyclic nucleotide research: a precautionary comment.
Wells JN; Kramer GL
Mol Cell Endocrinol; 1981 Jul; 23(1):1-9. PubMed ID: 6167475
[No Abstract] [Full Text] [Related]
15. Inhibition of cyclic AMP phosphodiesterase by 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-[2-(N-benzyl-N-methylamino)] ethyl ester 5-methyl ester hydrochloride (YC-93), a potent vasodilator.
Sakamoto N; Terai M; Takenaka T; Maeno H
Biochem Pharmacol; 1978; 27(8):1269-74. PubMed ID: 81059
[No Abstract] [Full Text] [Related]
16. Different sensitivites of cyclic nucleotide phosphodiesterases of rat brain and lung to inhibition by new anti-allergic chromones [proceedings].
Saeed SA; Butt NM; Spicer JW; Warren BT
Biochem Soc Trans; 1979 Dec; 7(6):1308-10. PubMed ID: 231533
[No Abstract] [Full Text] [Related]
17. Measurements of cyclic AMP and cyclic GMP phosphodiesterase activity in isolated tubular segments.
Jackson BA; Edwards RM; Dousa TP
Kidney Int; 1980 Oct; 18(4):512-8. PubMed ID: 6164816
[No Abstract] [Full Text] [Related]
18. Effect of inhibitors of cyclic nucleotide phosphodiesterases on electrical and contractile activity of smooth muscle cells.
Kovalev IV; Popov AG; Baskakov MB; Minochenko IL; Kilin AA; Borodin YL; Anfinogenova YD; Kapilevich LV; Medvedev MA
Bull Exp Biol Med; 2002 Jan; 133(1):38-40. PubMed ID: 12170302
[TBL] [Abstract][Full Text] [Related]
19. Cyclic nucleotide phosphodiesterase in heart and aorta of spontaneously hypertensive rats.
Sharma RV; Bhalla RC
Biochim Biophys Acta; 1978 Oct; 526(2):479-88. PubMed ID: 214127
[No Abstract] [Full Text] [Related]
20. Chromatographic behavior of cyclic 3',5'-nucleotide phosphodiesterases on columns of immobilized inhibitors.
Mohindru A; Chenet A; Rhoads AR
Biochemistry; 1978 Aug; 17(16):3297-304. PubMed ID: 80229
[No Abstract] [Full Text] [Related]
[Next] [New Search]
